HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Avon

This article was originally published in The Rose Sheet

Executive Summary

Avon: Fourth quarter earnings are expected to be "negatively affected by results in several markets," including Brazil, the U.S., China and Japan, Avon announced Nov. 17. The company is "on track," however, with year-end sales and earnings estimates, the direct marketer said. In the U.S., results for the quarter will be "below earlier expectations," while "further weakness" in Japan, coupled with "tougher regulatory requirements" for direct marketers in China, "slowed sales growth" in the Asia-Pacific region, Avon said. In addition, "aggressive" marketing programs in Brazil are not "generating the expected sales increase in the quarter," partly due to "consumer reaction to growing economic concerns"...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004864

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel